NCT05520645

Etomidate Induction in Hysteroscopic Surgery

Randomized Controlled Study of Etomidate Induction in Hysteroscopic Surgery

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Peking University Third Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study intends to study the optimal dose induced by etomidate in outpatients undergoing painless hysteroscopic surgery. At present, the dosage in the user manual is 0.1-0.3mg/kg. In clinical use, it is found that 0.1mg/kg often fails to achieve sedative effect, and 0.3mg/kg is prone to muscle twitching. Therefore, three groups of doses of 0.15mg/kg, 0.2mg/kg and 0.25mg/kg are set. It is hoped that this study will provide a basis for clinical evaluation of etomidate in anesthesia induction of hysteroscopic surgery.

Conditions

• Etomidate Induced Dose
• Hysteroscopic Surgery

Interventions

Type	Name	Description
DRUG	etomidate	use etomidate for anesthesia induction in hysteroscopic surgery
DRUG	propofol	use propofol for anesthesia induction in hysteroscopic surgery

Timeline

• Start date: 2022-08-25
• Primary completion: 2023-09-30
• Completion: 2023-12-30
• First posted: 2022-08-30
• Last updated: 2022-08-30